BridgeMD
New treatment option for Lumbar Radiculopathy
Official title Three-dimensional Lumbar Myofascial Release and Motor Control in Lumbar Radiculopathy
ClinicalTrials.gov ID: NCT06990113
What this study is testing
- What it's testing
- to investigate The Efficacy of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy Patients with lumbar radiculopathy demonstrate impairments in function and range of motion to deficits in patient's quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 50
You may be able to join if
- Their ages range from 35 to 50 years.
- Both sex
- Unilateral lumbar radiculopathy for more than 6 months.
- Normal body mass index (18.5 - 24.99Kg/m2).
You likely can't join if
- Any other musculoskeletal disorders of the spine or upper extremity
- Patients with any other Neurological deficits, psychiatric disease lumbar myelopathy, Cognitive problems, vertebral fractures and previous history of...
- Clinical instability, recent trauma
- Structural abnormalities of the spine, osteoporosis, and spasmodic torticollis.
- Inflammatory or other specific disorders of spina such as ankylosing spondylitis and rheumatoid arthritis
The study team makes the final eligibility decision.
Where it's taking place
- Al Jīzah, Select State, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Jīzah, Select State, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.